Condition
Emphysema, Pulmonary
Total Trials
3
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting3
Clinical Trials (3)
Showing 3 of 3 trials
NCT07731958Not ApplicableRecruitingPrimary
Unilateral vs. Bilateral Lung Volume Reduction Surgery
NCT06035120Not ApplicableRecruitingPrimary
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
NCT06655428Not ApplicableRecruiting
The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema
Showing all 3 trials